Clinical Trials
1.2k
Active:44
Completed:548
Trial Phases
6 Phases
Early Phase 1:4
Phase 1:10
Phase 2:91
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (953 trials with phase data)• Click on a phase to view related trials
Not Applicable
739 (77.5%)Phase 2
91 (9.5%)Phase 4
72 (7.6%)Phase 3
37 (3.9%)Phase 1
10 (1.0%)Early Phase 1
4 (0.4%)A Double-Blind, Sham-Controlled Trial Investigating Individualized Alpha Neurofeedback Plus Cognitive Training in Paediatric Brain Tumour Survivors
Not Applicable
Not yet recruiting
- Conditions
- Brain Tumor, Primary
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 50
- Registration Number
- NCT07085494
Evaluating the Efficacy of a Text Messaging-based Shisha Smoking Cessation Intervention
Not Applicable
Not yet recruiting
- Conditions
- InterventionControl
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 100
- Registration Number
- NCT07070154
- Locations
- 🇭🇰
Room 212, New Clinical Building, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, Hong Kong
Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI Perfusion
Not Applicable
Recruiting
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2025-07-16
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 100
- Registration Number
- NCT07068399
- Locations
- 🇭🇰
HKU Li Ka Shing Faculty of Medicine, Hong Kong, Hong Kong
Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity
Not Applicable
Not yet recruiting
- Conditions
- Osteoarthritis (OA) of the Knee
- Interventions
- Other: Placebo
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 100
- Registration Number
- NCT07065591
Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 Inhibitor
Not Applicable
Not yet recruiting
- Conditions
- Metabolic Syndrome
- Interventions
- Other: Matching placebo
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 160
- Registration Number
- NCT07065357
- Prev
- 1
- 2
- 3
- 4
- 5
- 230
- Next
News
No news found